It was reported to boston scientific corporation that a spaceoar vue device was implanted during a spaceoar vue placement procedure on (b)(6) 2024.Fiducial markers were placed the same day.After the procedure, the physician reported a potential injection into the rectal wall.Two weeks later, the physician did not use a catheter during a simulation due to the patient's rectal pain.The patient noted that he had experienced pain since the hydrogel placement and that he was having constipation problems.As a treatment for constipation, the patient was prescribed miralax and a stool softener to help facilitate bowel movements.The patient is currently experiencing pain.The patient will receive conventional fractionation over stereotactic body radiation treatment (sbrt).
|